CSIR in the news..

An aggregation of news on the web about CSIR and its laboratories

Buyouts skew Indian drug industry

22 Febrary 2011

Tie-ups between Indian drug companies and multinational pharmaceutical firms, which initially received a lot of media attention, have proven to be more beneficial for big pharma than for Indian companies, according to a recent study.

The study authors found that co-operation between multinational pharmaceutical companies and Indian manufacturers had not boosted the R & D capacity of Indian pharmaceutical businesses.

They also found that there had not been any significant transfer of technology from developed countries.

…….Study author Dinesh Abrol, of the  National Institute of Science, Technology and Development Studies (NISTADS), said that  buying domestic Indian companies would give multinational companies fewer challenges over proprietary technology.

He said that the buyouts would ultimately lead to decreased manufacturing capacity for Indian-made generic drugs…….

Read more: http://www.hc2d.co.uk/content.php?contentId=17654


Written by csirindia

February 23, 2011 at 9:58 am

Posted in NISTADS

%d bloggers like this: